OBJECTIVE: Low-gradient (LG) severe aortic stenosis (AS) and preserved EF with reduced stroke volume are associated with an adverse prognosis, but the relationship of stroke volume index (SVI) with mortality among a range of values is unknown. We investigated the prognostic impact of SVI in this population. METHODS: We examined 405 consecutive patients with preserved EF (≥50%) and severe AS (valve area <1.0 cm(2)) with LG (<40 mm Hg) using echocardiography. Patients were stratified into quartiles based on SVI distribution (group 1: <38 mL/m(2) (n=90), group 2: 38-43 mL/m(2) (n=105), group 3: 43-48 mL/m(2) (n=104) and group 4: >48 mL/m(2) (n=106)). RESULTS: Groups 1 and 2 had poorer survival with medical management compared with 3 and 4 (3-year estimate 46% and 67% vs. 78% and 73%, respectively, p=0.002) although aortic valve replacement referral rate was similar (53%-62%, p=0.57). An inverse relationship was observed between SVI and mortality (HR 1.28 (1.11 to 1.46) per every 5 mL/m(2) decrease in SVI). After multivariable analysis, SVI was the strongest predictor of mortality (HR 0.92 (0.89 to 0.95), p<0.0001). Using different SVI cutpoints, SVI <35 was associated with highest mortality (HR 2.36 (1.49 to 3.73), p<0.001), followed by SVI <38 (HR 2.09 (1.39 to 3.16), p<0.001) and by SVI <43 (HR 2.05 (1.38 to 3.05), p<0.001). Survival with SVI ≥43 was similar to age and sex-matched controls (3-year estimate 84%, p=0.24); survival for SVI <43 was significantly worse (3-year estimate 63%, p<0.001). CONCLUSIONS: Lower SVI is incrementally associated with mortality in LG severe AS with preserved EF. These findings have implications for classification of AS severity, identification of high-risk groups and subsequent management. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE: Low-gradient (LG) severe aortic stenosis (AS) and preserved EF with reduced stroke volume are associated with an adverse prognosis, but the relationship of stroke volume index (SVI) with mortality among a range of values is unknown. We investigated the prognostic impact of SVI in this population. METHODS: We examined 405 consecutive patients with preserved EF (≥50%) and severe AS (valve area <1.0 cm(2)) with LG (<40 mm Hg) using echocardiography. Patients were stratified into quartiles based on SVI distribution (group 1: <38 mL/m(2) (n=90), group 2: 38-43 mL/m(2) (n=105), group 3: 43-48 mL/m(2) (n=104) and group 4: >48 mL/m(2) (n=106)). RESULTS: Groups 1 and 2 had poorer survival with medical management compared with 3 and 4 (3-year estimate 46% and 67% vs. 78% and 73%, respectively, p=0.002) although aortic valve replacement referral rate was similar (53%-62%, p=0.57). An inverse relationship was observed between SVI and mortality (HR 1.28 (1.11 to 1.46) per every 5 mL/m(2) decrease in SVI). After multivariable analysis, SVI was the strongest predictor of mortality (HR 0.92 (0.89 to 0.95), p<0.0001). Using different SVI cutpoints, SVI <35 was associated with highest mortality (HR 2.36 (1.49 to 3.73), p<0.001), followed by SVI <38 (HR 2.09 (1.39 to 3.16), p<0.001) and by SVI <43 (HR 2.05 (1.38 to 3.05), p<0.001). Survival with SVI ≥43 was similar to age and sex-matched controls (3-year estimate 84%, p=0.24); survival for SVI <43 was significantly worse (3-year estimate 63%, p<0.001). CONCLUSIONS: Lower SVI is incrementally associated with mortality in LG severe AS with preserved EF. These findings have implications for classification of AS severity, identification of high-risk groups and subsequent management. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Paolo Milani; Angela Dispenzieri; Christopher G Scott; Morie A Gertz; Stefano Perlini; Roberta Mussinelli; Martha Q Lacy; Francis K Buadi; Shaji Kumar; Mathew S Maurer; Giampaolo Merlini; Suzanne R Hayman; Nelson Leung; David Dingli; Kyle W Klarich; John A Lust; Yi Lin; Prashant Kapoor; Ronald S Go; Patricia A Pellikka; Yi L Hwa; Stephen R Zeldenrust; Robert A Kyle; S Vincent Rajkumar; Martha Grogan Journal: Circ Cardiovasc Imaging Date: 2018-05 Impact factor: 7.792
Authors: Nisha Hosadurg; Benjamin Koethe; Dou Huang; Andrew R Weintraub; Ayan R Patel; Benjamin S Wessler Journal: J Am Soc Echocardiogr Date: 2020-09-02 Impact factor: 5.251
Authors: Mackram F Eleid; Hector I Michelena; Vuyisile T Nkomo; Rick A Nishimura; Joseph F Malouf; Christopher G Scott; Patricia A Pellikka Journal: Eur Heart J Cardiovasc Imaging Date: 2015-04-20 Impact factor: 6.875
Authors: Koichi Nishimura; Marko Oydanich; Jie Zhang; Denis Babici; Diego Fraidenraich; Dorothy E Vatner; Stephen F Vatner Journal: Am J Physiol Regul Integr Comp Physiol Date: 2020-03-25 Impact factor: 3.619
Authors: Mohammed Y Khanji; Fabrizio Ricci; Victor Galusko; Baskar Sekar; C Anwar A Chahal; Laura Ceriello; Sabina Gallina; Simon Kennon; Wael I Awad; Adrian Ionescu Journal: Eur Heart J Qual Care Clin Outcomes Date: 2021-07-21
Authors: Iacopo Fabiani; Cristian Scatena; Chiara Maria Mazzanti; Lorenzo Conte; Nicola Riccardo Pugliese; Sara Franceschi; Francesca Lessi; Michele Menicagli; Andrea De Martino; Stefano Pratali; Uberto Bortolotti; Antonio Giuseppe Naccarato; Salvatore La Carrubba; Vitantonio Di Bello Journal: J Transl Med Date: 2016-08-27 Impact factor: 5.531